TNF and rheumatoid arthritis: In the collagen-induced rheumatoid arthritis model, CD200Fc treatment significantly lowers expression of pro-inflammatory cytokines (IL-1β and TNFα) and lowers disease severity at 10 days post disease induction (16, 17).